Antonella L. Cammarota

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

The role of circulating tumor DNA (ctDNA) to detect minimal residual disease in locally advanced gastroesophageal carcinoma: the BUTTERFLY study.

The role of circulating tumor DNA (ctDNA) to detect minimal residual disease in locally advanced gastroesophageal carcinoma: the BUTTERFLY study.

Journal: ESMO gastrointestinal oncology

Published: September 03, 2026

Real-World Pattern of Care Analysis of Liver Reirradiation Among European Organisation for Research and Treatment of Cancer Members.

Real-World Pattern of Care Analysis of Liver Reirradiation Among European Organisation for Research and Treatment of Cancer Members.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: May 13, 2026

The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm.

The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm.

Journal: The lancet. Gastroenterology & hepatology

Published: February 09, 2026

Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study.

Research training, barriers, and career development needs of early-career investigators in oncology: an EORTC survey-based study.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.

Circulating tumour DNA in oligometastatic oesophago-gastric cancers: applications, challenges, and future directions.

Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Published: February 05, 2026

Promising investigational agents for gastro-oesophageal junction adenocarcinoma.

Promising investigational agents for gastro-oesophageal junction adenocarcinoma.

Journal: Expert opinion on investigational drugs

Published: December 19, 2025

Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study.

Prognostic impact of pathological complete response and response-adapted outcomes in patients with gastroesophageal adenocarcinoma treated with neoadjuvant or perioperative treatments: a multicentric cohort study.

Journal: ESMO open

Published: September 13, 2025

Are we closing the gender gap in academic oncology? An observational study of gender disparities in participant engagement at the ASCO 2024 annual meeting.

Are we closing the gender gap in academic oncology? An observational study of gender disparities in participant engagement at the ASCO 2024 annual meeting.

Journal: BMJ open

Published: September 10, 2025

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis.

Epidemiology, clinical, molecular features, and prognosis of early-onset biliary tract cancer: A systematic review and meta-analysis.

Journal: JHEP reports : innovation in hepatology

Published: July 01, 2025

Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trials.

Toxicity and efficacy of antibody-drug conjugates in advanced solid tumors: a retrospective single-center analysis of clinical trials.

Journal: ESMO open

Published: May 23, 2025

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials.

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials.

Journal: JCO precision oncology

Published: April 16, 2025

Immunotherapy plus tyrosine-kinase inhibitors in hepatocellular carcinoma.

Immunotherapy plus tyrosine-kinase inhibitors in hepatocellular carcinoma.

Journal: The Lancet. Oncology

Published: April 02, 2025

Showing 1-12 of 50

Last Updated: 09/26/2026